Succor Combat Foam
Phase 2- Indications
- Burn wounds, Combat wounds, Dermal injuries
Company intelligence / Profile preview
Critical Innovations has developed several medical devices targeting acute health threats in pre-hospital, hospital, and military settings. Their Rx-Shooter wearable wound infection treatment device is advancing through prototype refinement and preclinical animal studies. The company has received significant federal funding for R&D but does not yet have commercialized products on the market
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Critical Innovations.